The Effects of Ezetimibe and/or Orlistat on Triglyceride-Rich Lipoprotein Metabolism in Obese Hypercholesterolemic Patients
Author:
Publisher
Wiley
Subject
Cell Biology,Organic Chemistry,Biochemistry
Reference48 articles.
1. Jong MC, Hofker MH, Havekes LM (1999) Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol 19:472–484
2. Wang CS (1991) Structure and functional properties of apolipoprotein C-II. Prog Lipid Res 30:253–258
3. Chan DC, Chen MM, Ooi EM, Watts GF (2008) An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor? Int J Clin Pract 62:799–809
4. Filippatos TD, Mikhailidis DP (2009) Lipid-lowering drugs acting at the level of the gastrointestinal tract. Curr Pharm Des 15:490–516
5. Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, Crona JH, Davis HR Jr, Dean DC, Detmers PA, Graziano MP, Hughes M, Macintyre DE, Ogawa A, O’Neill KA, Iyer SP, Shevell DE, Smith MM, Tang YS, Makarewicz AM, Ujjainwalla F, Altmann SW, Chapman KT, Thornberry NA (2005) The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci USA 102:8132–8137
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles;Journal of Clinical Medicine;2021-12-21
2. Current Diagnosis and Management of Primary Chylomicronemia;Journal of Atherosclerosis and Thrombosis;2021-09-01
3. ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets;Current Atherosclerosis Reports;2021-03-10
4. Efficacy of orlistat in non‑alcoholic fatty liver disease: A systematic review and meta‑analysis;Biomedical Reports;2018-05-22
5. Pathophysiology of Diabetic Dyslipidaemia;Current Vascular Pharmacology;2017-09-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3